Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08
Published March 25, 2020 · Recall initiated: February 17, 2020
Summary
FDA records drug Class III recall D-1029-2020, published March 25, 2020 and initiated February 17, 2020. Recalling firm: Strides Pharma Science Limited; Status: Terminated; Reported quantity: 2576 bottles; Lot: Lot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email if POTASSIUM CHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- POTASSIUM CHLORIDE
- Manufacturer
- Strides Pharma Science Limited
- Distributor
- U.S.A. Nationwide
- UPC
- 0364380860068
- Lot
- Lot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAPOTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL Flexible Container, Highly concentrated 100 mEq/L, Rx Only,November 26, 2025
- FDAPOTASSIUM CHLORIDE Inj., 20 mEq total in 50 mL Flexible Container, Highly concentrated 400 mEq/L, Rx Only, ICUNovember 26, 2025
- FDAPOTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL, 100 mEq/L flexible container, Rx Only, ICU Medical, Inc.,March 19, 2025
- FDAPOTASSIUM CHLORIDE Inj., 20 mEq total in 100 mL flexible container 24 x case, 200 mEq/L, Rx Only, ICU Medical,March 19, 2025
- FDAMaximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 200 tablets per bottle. [Brand, NDC] NDC BasicMarch 25, 2020
- FDALisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202,March 25, 2020
Questions about this recall
Was Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08 recalled?
Yes. FDA published recall D-1029-2020 on March 25, 2020. Reported hazard: Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: POTASSIUM CHLORIDE. UPC: 0364380860068.